Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Anti-IL1RAP CAN-10 antibody shows promise in the treatment of systemic sclerosis

March 16, 2022

Researchers develop a new Tpi1-mutated murine model of TPI deficiency

March 16, 2022

Regulation of BIN1 ameliorates dynamin-related myopathy

March 7, 2022

New mucolipin-1 agonists divulged by Casma Therapeutics

March 4, 2022

Roche divulges new TLR7/8/9 antagonists

March 3, 2022

Kira Pharmaceuticals discovers C5aR antagonists

March 1, 2022

New complement factor B inhibitors identified at Shanghai Meiyue Biotech Development

March 1, 2022

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Feb. 28, 2022

Osteocytic Cx43 hemichannels as new therapeutic target for treating bone loss and osteoporosis

Feb. 25, 2022

Shaanxi Synthetic Pharmaceutical presents new thiobenzopyran compounds

Feb. 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...